Time course of regression of left ventricular hypertrophy after successful parathyroidectomy

Surgery

Volumn 121, Issue 2, 1997, Pages 157-161

  Stefenelli, Thomas ^a   Abela, Claudette ^a   Frank, Herbert ^a   Koller Strametz, Jeanette ^a   Niederle, Bruno ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLLAGEN METABOLISM; DEFENSE MECHANISM; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MALE; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

EID: 0031048747     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(97)90285-3     Document Type: Article

References (25)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-6.
2. Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 1992;117:831-6.
3. Koren MJ, Ulin RJ, Laragh JH, Devereux RB. Reduction in left ventricular mass during treatment of essential hypertension is associated with improved prognosis [abstract]. Am J Hypertens 1991;4:1A.
4. Cruickshank JM, Lewis J, Moore V, Dodd C. Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy. J Hum Hypertens 1992;6:85-90.
5. Dahlöf B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients - a metaanalysis of 109 treatment studies. Am J Hypertens 1992;5:95-110.
6. Clement DL, De Buyzere M, Duprez D. Left ventricular function and regression of left ventricular hypertrophy in essential hypertension. Am J Hypertens 1993;6:14S-9S.
7. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975;56:56-64.
8. Monrad ES, Hess QM, Murakami T, Nonogi H, Corin WJ, Krayenbuehl HP. Time course of regression of left ventricular hypertrophy after aortic valve replacement. Circulation 1988;77:1345-55.
9. Ganguly PK, Lee S-L, Beamish RE, Dhalla NS. Altered sympathetic system and adrenoceptors during the development of cardiac hypertrophy. Am Heart J 1989;118:520-5.
10. Kojima S, Wikman-Coffelt J. Genetic and cellular mechanisms of hypertrophy. J Hypertens In press.
11. Niederle B, Stefenelli T, Glogar D, Woloszczuk W, Roka R, Mayr H. Cardiac calcific deposits in patients with primary hyperparathyroidism: preliminary results of an echocardiographic study. Surgery 1990;108:1052-7.
12. Stefenelli T, Mayr H, Bergler Klein J, Globits S, Woloszczuk W, Niederle B. Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med 1993;95:197-202.
13. Längle F, Abela C, Koller-Strametz J, Mittelböck M, Bergler-Klein J, Stefenelli T, et al. Primary hyperparathyroidism and the heart: cardiac abnormalities correlated to clinical and biochemical data. World J Surg 1994;18:619-24.
14. Stefenelli T, Abela J, Frank H, Koller-Strametz J, Globits S, Bergler-Klein J, et al. Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow up. J Clin Endocrinol Metab In press.
15. Symons C, Fortune F, Greenbaum RA, Dandona P. Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism - an association. British Heart Journal 1985;54:539-42.
16. Stefenelli T, Globits S, Kratochwill C, Vierhapper H, Niederle B. Myocardial calcific deposits in Wermer syndrome (multiple endocrine neoplasia type I). Wien Klin Wochenschr 1992;104:698-700.
17. Smogorzewski M, Zayed M, Zhang YB, Roe J, Massry SG. Parathyroid hormone increases cytosolic calcium concentration in adult rat cardiac myocytes. Am J Physiol 1993;264:H1998-2006.
18. Sato S, Ohta M, Kawaguchi Y, Okada H, Ono M, Saito H, et al. Effects of parathyroidectomy on left ventricular mass in patients with hyperparathyroidism. Miner Electrolyte Metab 1995;21:67-71.
19. Arai M, Matsui H, Periasamy M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res 1994;74:555-64.
20. Marban E, Koretsune Y. Cell calcium, oncogenes, and hypertrophy. Hypertension 1990;15:652-8.
21. Drayer JI, Gardin JM, Weber MA, Aronow WS. Changes in ventricular septal thickness during diuretic therapy. Clin Pharmacol Ther 1982;32:283-91.
22. Drayer JI, Weber MA, Gardin JM, Lipson JL. Effect of long-term antihypertensive therapy on cardiac anatomy in patients with essential hypertension. Am J Med 1983;75(suppl 3A): 116-20.
23. Franz IW, Ketelhut R, Behr U, Tönnesmann U. Long-term studies of left ventricular hypertrophy. J Cardiovasc Pharmacol 1991;17(suppl 2):S87-93.
24. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991;83:1849-65.
25. Motz W, Vogt M, Scheler S, Strauer BE. Pharmacotherapeutic effects of antihypertensive agents on myocardium and coronary arteries in hypertension. Eur Heart J 1992;13(suppl D):100-6.